Arrhythmias and vagus nerve stimulation

Area of Science:

• Cardiology
• Neuroscience
• Medical Devices

Background:

• Vagal nerve stimulation (VNS) is an established therapy for epilepsy and depression.
• VNS enhances vagal tone, offering a potential novel treatment for heart failure.
• Beyond its chronotropic and inotropic effects, VNS significantly impacts cardiac electrophysiology and arrhythmogenesis.

Purpose of the Study:

• To review the intricate relationship between VNS and cardiac arrhythmias.
• To evaluate VNS as a therapeutic strategy for cardiac conditions.
• To identify electrophysiological alterations induced by VNS that could pose arrhythmogenic risks.

Main Methods:

• Literature review of studies on VNS and cardiac electrophysiology.
• Analysis of VNS effects on heart rate, contractility, and conduction.
• Examination of VNS-induced changes in cardiac electrical activity and arrhythmia susceptibility.

Main Results:

• VNS exhibits complex effects on cardiac electrophysiology, influencing action potential duration and refractoriness.
• While VNS can suppress certain arrhythmias, it may also create an arrhythmogenic substrate under specific conditions.
• The impact of VNS on cardiac rhythm is dose-dependent and modulated by underlying cardiac health.

Conclusions:

• VNS is a promising therapeutic avenue for heart failure, but its effects on cardiac electrophysiology require careful consideration.
• Understanding the dual role of VNS in modulating cardiac arrhythmias is crucial for safe and effective clinical application.
• Further research is needed to optimize VNS parameters and mitigate potential arrhythmogenic risks in patients with heart conditions.